|
TMCO7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.42690004256707E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.52329998299217E-09 |
| Normal-vs-Stage2 |
3.543400E-03 |
| Normal-vs-Stage3 |
2.59319999917906E-08 |
| Normal-vs-Stage4 |
1.30230000117137E-08 |
| Stage1-vs-Stage2 |
1.308200E-01 |
| Stage1-vs-Stage3 |
3.151200E-01 |
| Stage1-vs-Stage4 |
1.128760E-01 |
| Stage2-vs-Stage3 |
5.716100E-02 |
| Stage2-vs-Stage4 |
2.163600E-02 |
| Stage3-vs-Stage4 |
4.824600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.14860026939812E-10 |
| Normal-vs-AfricanAmerican |
1.067240E-01 |
| Normal-vs-Asian |
3.72060000000118E-05 |
| Caucasian-vs-AfricanAmerican |
7.597600E-03 |
| Caucasian-vs-Asian |
5.877800E-01 |
| AfricanAmerican-vs-Asian |
5.758400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.21769977118925E-10 |
| Normal-vs-Female |
2.34120000053295E-08 |
| Male-vs-Female |
1.042630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.83820000332346E-08 |
| Normal-vs-Age(41-60Yrs) |
1.96970000310159E-08 |
| Normal-vs-Age(61-80Yrs) |
2.13140000004941E-06 |
| Normal-vs-Age(81-100Yrs) |
9.360500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.097600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.553600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.053600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.343600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.730000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.546000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.515530E-02 |
| Classical-VS-Follicular |
9.754400E-01 |
| Classical-VS-Other |
3.364500E-02 |
| Classical-VS-Normal |
3.84210000481389E-08 |
| Tall-VS-Follicular |
1.980280E-02 |
| Tall-VS-Other |
3.241600E-01 |
| Tall-VS-Normal |
1.64279999603778E-08 |
| Follicular-VS-Other |
7.474300E-02 |
| Follicular-VS-Normal |
3.68710000000494E-05 |
| Other-VS-Normal |
7.97980000000198E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33049999964763E-07 |
| Normal-vs-N1 |
1.7542000074755E-09 |
| N0-vs-N1 |
8.755700E-03 |
|
|
